BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2587951)

  • 21. Group A streptococcal bacteremia in a community teaching hospital--1980-1989.
    Burkert T; Watanakunakorn C
    Clin Infect Dis; 1992 Jan; 14(1):29-37. PubMed ID: 1571444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serratia infections in a British hospital.
    Ghoneim AT; Day ME
    J Hosp Infect; 1980 Sep; 1(3):229-36. PubMed ID: 6182216
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.
    Lin YC; Chen TL; Ju HL; Chen HS; Wang FD; Yu KW; Liu CY
    J Microbiol Immunol Infect; 2006 Feb; 39(1):67-72. PubMed ID: 16440126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of nosocomial infection due to Gram-negative bacilli: aspects relevant to development and use of vaccines.
    Stamm WE; Martin SM; Bennett JV
    J Infect Dis; 1977 Aug; 136 Suppl():S151-60. PubMed ID: 330774
    [No Abstract]   [Full Text] [Related]  

  • 25. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endemic Serratia marcescens in the Veterans Administration Hospital in Pittsburgh, Pa., 1971--1976.
    Brown A; Davis L; Yee RB; Postic B
    Health Lab Sci; 1978 Jul; 15(3):159-67. PubMed ID: 359506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nosocomial urinary tract infection with Serratia marcescens: an epidemiologic study.
    Maki DG; Hennekens CG; Phillips CW; Shaw WV; Bennett JV
    J Infect Dis; 1973 Nov; 128(5):579-87. PubMed ID: 4588701
    [No Abstract]   [Full Text] [Related]  

  • 28. Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis.
    Gatell JM; Trilla A; Latorre X; Almela M; Mensa J; Moreno A; Miro JM; Martinez JA; Jimenez de Anta MT; Soriano E
    Rev Infect Dis; 1988; 10(1):203-10. PubMed ID: 3353630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nosocomial bacteremia caused by Acinetobacter].
    Moreno S; Vicente T; Armas M; Bernaldo de Quirós JC; Rodríguez-Créixems M; Bouza E
    Enferm Infecc Microbiol Clin; 1990 Dec; 8(10):606-9. PubMed ID: 2098118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and microbiological features of Providencia bacteremia: experience at a tertiary care hospital.
    Choi HK; Kim YK; Kim HY; Park JE; Uh Y
    Korean J Intern Med; 2015 Mar; 30(2):219-25. PubMed ID: 25750564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serratia marcescens infection of the urinary tract: a nosocomial infection.
    Allen SD; Conger KB
    J Urol; 1969 Apr; 101(4):621-3. PubMed ID: 4887310
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of community-acquired and nosocomial pneumococcal bacteremia.
    Mylotte JM; Beam TR
    Am Rev Respir Dis; 1981 Mar; 123(3):265-8. PubMed ID: 7013585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nosocomial bacteremia caused by Enterobacter spp.: epidemiology and prognostic factors].
    Peña C; Pujol M; Pallarés R; Cisnal M; Ariza J; Gudiol F
    Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):424-8. PubMed ID: 8260514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
    Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
    J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for mortality in patients with Serratia marcescens bacteremia.
    Kim SB; Jeon YD; Kim JH; Kim JK; Ann HW; Choi H; Kim MH; Song JE; Ahn JY; Jeong SJ; Ku NS; Han SH; Choi JY; Song YG; Kim JM
    Yonsei Med J; 2015 Mar; 56(2):348-54. PubMed ID: 25683980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epidemiologic and therapeutic aspects of bacteremic infections of the urinary tract].
    Tomás S; Torné J; Soriano JC; García-Flores A; Garcés JM; Drobnic L; Morta M; Torres JM
    Enferm Infecc Microbiol Clin; 1989 Feb; 7(2):67-71. PubMed ID: 2490670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and risk factors for mortality in Morganella morganii bacteremia.
    Lee IK; Liu JW
    J Microbiol Immunol Infect; 2006 Aug; 39(4):328-34. PubMed ID: 16926980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacteremia in a long-term-care facility: a five-year prospective study of 163 consecutive episodes.
    Muder RR; Brennen C; Wagener MM; Goetz AM
    Clin Infect Dis; 1992 Mar; 14(3):647-54. PubMed ID: 1562655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nosocomial bacteremia in perspective: a community-wide study.
    Brenner ER; Bryan CS
    Infect Control; 1981; 2(3):219-26. PubMed ID: 6912212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Enterobacter, Serratia, Acinetobacter or Pseudomonas septicemias].
    Billiau V; Beuscart C; Leroy O; Dujardin PJ; Beaucaire G; Chidiac C; Mouton Y; Ses G
    Pathol Biol (Paris); 1989 Jan; 37(1):39-42. PubMed ID: 2648268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.